Sign inGet started

Greene John

Insider CIK 1610732 · NOC CVP & Chief Financial Officer · WSH Chief Financial Officer · DFS EVP, Chief Financial Officer · CRSP Director · BIVV EVP, CFO and Treasurer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CRSP CRISPR Therapeutics AG A Award deriv2026-06-052026-06-0913,000— $013,000SEC↗
NOC NORTHROP GRUMMAN CORP /DE/ A Award deriv2026-02-112026-02-135,362— $05,362SEC↗
NOC NORTHROP GRUMMAN CORP /DE/ A Award deriv2026-02-112026-02-134,981— $04,981SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2025-06-052025-06-0613,000— $013,000SEC↗
DFS Discover Financial Service D To issuer2025-05-182025-05-1979,943— $00SEC↗
CRSP CRISPR Therapeutics AG P Buy2025-02-262025-02-287,000$44.85 $313.9K7,000SEC↗
DFS Discover Financial Service F Tax w/h2025-02-012025-02-041,840$201.09 $370.0K79,866SEC↗
DFS Discover Financial Service A Award2025-01-232025-01-2714,630— $081,706SEC↗
DFS Discover Financial Service A Award2024-12-192024-12-2312,109— $078,778SEC↗
DFS Discover Financial Service F Tax w/h2024-12-192024-12-2311,702$169.27 $1.98M67,076SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2024-05-302024-05-3113,000— $013,000SEC↗
DFS Discover Financial Service A Award2024-02-222024-02-2629,324— $057,427SEC↗
DFS Discover Financial Service A Award2024-02-222024-02-269,051— $066,478SEC↗
DFS Discover Financial Service A Award2024-02-012024-02-0521,801— $040,393SEC↗
DFS Discover Financial Service F Tax w/h2024-02-012024-02-0512,290$106.56 $1.31M28,103SEC↗
DFS Discover Financial Service F Tax w/h2024-02-012024-02-0512,290$106.56 $1.31M28,103SEC↗
DFS Discover Financial Service A Award2024-02-012024-02-0521,801— $040,393SEC↗
DFS Discover Financial Service S Sale2024-01-262024-01-3035,191$106.51 $3.75M18,592SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2023-06-082023-06-0913,000— $013,000SEC↗
DFS Discover Financial Service A Award2023-02-232023-02-279,960— $053,539SEC↗
DFS Discover Financial Service F Tax w/h2023-02-012023-02-0314,083$115.83 $1.63M43,579SEC↗
DFS Discover Financial Service A Award2023-02-012023-02-0325,196— $057,662SEC↗
DFS Discover Financial Service F Tax w/h2022-08-012022-08-031,752$102.22 $179.1K32,275SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2022-06-092022-06-1012,000— $012,000SEC↗
DFS Discover Financial Service A Award2022-02-252022-03-017,339— $033,952SEC↗
DFS Discover Financial Service S Sale2022-02-152022-02-174,443$127.95 $568.5K26,613SEC↗
DFS Discover Financial Service F Tax w/h2022-02-012022-02-032,079$118.02 $245.4K31,056SEC↗
DFS Discover Financial Service F Tax w/h2021-08-012021-08-031,752$124.32 $217.8K33,135SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2021-06-102021-06-1410,000— $010,000SEC↗
DFS Discover Financial Service A Award2021-02-192021-02-239,690— $034,887SEC↗
DFS Discover Financial Service F Tax w/h2021-02-012021-02-031,146$82.19 $94.2K25,197SEC↗
DFS Discover Financial Service F Tax w/h2020-08-012020-08-031,159$49.43 $57.3K26,343SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2020-06-112020-06-1515,000— $015,000SEC↗
DFS Discover Financial Service P Buy2020-01-272020-01-273,377$73.84 $249.4K27,502SEC↗
DFS Discover Financial Service A Award2020-01-222020-01-2411,198— $024,125SEC↗
DFS Discover Financial Service A Award2019-09-182019-09-2011,861— $012,927SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2019-06-112019-06-1330,000— $030,000SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0842,727— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-08113,230— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0856,615— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0814,230— $00SEC↗
BIVV Bioverativ Inc. D To issuer2018-03-082018-03-085,951— $00SEC↗
BIVV Bioverativ Inc. M Exercise deriv2018-02-142018-02-157,114— $014,230SEC↗
BIVV Bioverativ Inc. F Tax w/h2018-02-142018-02-152,118$103.52 $219.3K5,496SEC↗
BIVV Bioverativ Inc. M Exercise2018-02-142018-02-157,114— $07,614SEC↗
BIVV Bioverativ Inc. A Award deriv2018-01-312018-02-0242,727— $042,727SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-16113,028— $0113,028SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1621,344— $021,344SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1656,514— $056,514SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-03-27113,230— $0113,230SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-03-2756,615— $056,615SEC↗
WLTW WILLIS TOWERS WATSON PLC A Award2016-01-042016-01-063,913— $014,805SEC↗
WSH WILLIS GROUP HOLDINGS PLC A Award deriv2015-11-092015-11-1239,964— $039,964SEC↗
WSH WILLIS GROUP HOLDINGS PLC A Award2015-11-092015-11-1215,323— $028,855SEC↗
WSH WILLIS GROUP HOLDINGS PLC F Tax w/h2015-11-092015-11-12804$44.14 $35.5K13,532SEC↗
WSH WILLIS GROUP HOLDINGS PLC A Award deriv2014-12-162014-12-1838,994— $038,994SEC↗
WSH WILLIS GROUP HOLDINGS PLC A Award2014-12-162014-12-185,183— $014,336SEC↗
WSH WILLIS GROUP HOLDINGS PLC A Award2014-08-112014-08-139,153— $09,153SEC↗